These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2136669)

  • 1. Reducing hospital use and expenditures through utilization review. Findings from an outcome evaluation.
    Wickizer TM; Feldstein PJ; Wheeler JR; McDonald MC
    Qual Assur Util Rev; 1990 Aug; 5(3):80-5. PubMed ID: 2136669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of utilization review on hospital use and expenditures: a covariance analysis.
    Wickizer TM
    Health Serv Res; 1992 Apr; 27(1):103-21. PubMed ID: 1563951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Have hospital inpatient cost containment programs contributed to the growth in outpatient expenditures? Analysis of the substitution effect associated with hospital utilization review.
    Wickizer TM; Wheeler JR; Feldstein PJ
    Med Care; 1991 May; 29(5):442-51. PubMed ID: 1902277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Private cost containment. The effects of utilization review programs on health care use and expenditures.
    Feldstein PJ; Wickizer TM; Wheeler JR
    N Engl J Med; 1988 May; 318(20):1310-4. PubMed ID: 3129660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does utilization review reduce unnecessary hospital care and contain costs?
    Wickizer TM; Wheeler JR; Feldstein PJ
    Med Care; 1989 Jun; 27(6):632-47. PubMed ID: 2725090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization review savings at the micro level.
    Khandker RK; Manning WG; Ahmed T
    Med Care; 1992 Nov; 30(11):1043-52. PubMed ID: 1434957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization management as a cost-containment strategy.
    Bailit HL; Sennett C
    Health Care Financ Rev Annu Suppl; 1991; ():87-93. PubMed ID: 10117120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of UR on hospital use.
    Wickizer TM; Feldstein PJ; Wheeler JR
    Bus Health; 1988 Jul; 5(9):28-30. PubMed ID: 10312598
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospital utilization review: past experience, future directions.
    Ermann D
    J Health Polit Policy Law; 1988; 13(4):683-704. PubMed ID: 3069901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of utilization review on costs and utilization.
    Khandker RK; Manning WG
    Dev Health Econ Public Policy; 1992; 1():47-62. PubMed ID: 10151753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does gatekeeping control costs for privately insured children? Findings from the 1996 medical expenditure panel survey.
    Pati S; Shea S; Rabinowitz D; Carrasquillo O
    Pediatrics; 2003 Mar; 111(3):456-60. PubMed ID: 12612221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relating health care market characteristics to the effectiveness of utilization review programs.
    Wheeler JR; Wickizer TM
    Inquiry; 1990; 27(4):344-51. PubMed ID: 2148307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between selective contracting and healthcare expenditures in private health insurance plans in the United States.
    van den Broek-Altenburg EM; Atherly AJ
    Health Policy; 2020 Feb; 124(2):174-182. PubMed ID: 31932076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UR only as good as what you save.
    Grobman M
    Bus Health; 1991 Jul; 9(7):20-2, 24, 26-30. PubMed ID: 10112452
    [No Abstract]   [Full Text] [Related]  

  • 15. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is utilization review paying off?
    Vibbert S
    Bus Health; 1989 Feb; 7(2):20-6. PubMed ID: 10293557
    [No Abstract]   [Full Text] [Related]  

  • 17. Corporate involvement in medical costs containment.
    Odynocki B
    Health Matrix; 1987-1988 Winter; 5(4):3-8. PubMed ID: 10302292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating health care delivery reform initiatives in the face of "cost disease".
    Thompson S; Kohli R; Jones C; Lovejoy N; McGraves-Lloyd K; Finison K
    Popul Health Manag; 2015 Feb; 18(1):6-14. PubMed ID: 25029411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.